India Business Excellence Fund – IV, a fund managed and advised by MOAlternate Investment Advisors (MOPE), has agreed to make a primary investment of up to Rs 194.4 crore in New Delhi-based startup Pathkind Diagnostics.

Vishal Tulsyan, MD and CEO, MOPE said, “This is our second investment in the diagnostics industry, the first one being in a leading medical equipment company, which is decentralising access to quality diagnostics. With our investment in Pathkind, we are further augmenting access to quality diagnostic testing infrastructure across India.”

Sanjeev Vashishta, Promoter, MD and CEO, Pathkind Diagnostics said, “The funding will be utilised judiciously to further build on the diagnostics capabilities and capacities, educating the masses about the virtues of early diagnosis and to augment our services using digitisation, AI, ML tools apart from other things.”

Eklavya Juneja, Director & Promoter Pathkind Diagnostics said, “This primary investment coming in Pathkind will be utilised to further develop our IT infrastructure, digital marketing and expansion into southern India making us a Pan-India player within six months."